Interview: Stuart Quin, CEO, Medica Group

What is the outlook for the UK teleradiology sector, with the largest player Medica's elective volumes still less than half of pre-COVID levels? We talk to CEO Stuart Quin about the group's recent H1 results and its strategy around specialist reporting, AI solutions, diversification and internationalisation, the latter of which has shifted since we last spoke.

Interview: Jan Leister, executive director of digital health, Fresenius Helios

Fresenius Helios has a new incoming digital health executive, who after heading up the Fresenius Group's German rehab business for the past four years wants to disrupt the way it manages chronic disease by transforming it from a pure hospital operator into a digi-physical healthcare group. Leister tells HBI that he wants to sell its digital therapeutics solution Curalie right into emerging markets.

Interview: Nasser Al Hagbani, CEO, Dr. Sulaiman Al Habib Medical Services Group

Saudi/UAE hospital operator Dr. Sulaiman Al Habib Medical Services Group (HmG) is by far the largest player by revenue in the GCC at $1.3bn. Shares have all but doubled since its IPO in March, making it the sixth-largest hospital stock globally by market capitalisation at $8.5bn. Its lucrative tele-ICU centre is the largest in the world by beds monitored. In this exclusive interview, Hagbani discusses HmG's listing, business model, Saudisation efforts, declining expat market and of course COVID-19.

Interview: James Thorburn, CEO, City & County Healthcare

The CEO of City & County Healthcare, the second-largest domiciliary care provider in the UK with 2019 revenue of £ 236m, tells HBI how the company is navigating the COVID-19 crisis and what prospects are now like for a sale.

Interview: Stefan Nilsson, Colosseum Dental Group CEO

HBI talks to Stefan Nilsson, CEO of Colosseum Dental Group, the Swiss-based pan-European chain with a presence in Finland, Norway, Sweden, Switzerland, Italy, Denmark, Germany and the UK, about how it has weathered COVID, and its plans going forward as we all adapt to the new normal.

Interview: David Hadley, CEO, Mediclinic Middle East

EMEA hospital group Mediclinic International is undergoing its last substantial capital project in the UAE for the foreseeable future, Middle East CEO David Hadley tells HBI, as the group switches expansionary focus to neighbouring Saudi Arabia. We discuss the two markets and the reasons for the segment's recent $600m+ impairment charge.

Interview: Pablo Pantaleoni, VP of global strategy, Headspace

Headspace started a decade ago as a meditation app founded by a Buddhist monk. It is now one of the world's most successful consumer B2C businesses with 65m downloads, 2m paying subscribers and north of $50m revenue. HBI speaks to Pablo Pantaleoni who is leading the early stages of clinical trials for digital therapeutics (DTx) through its medical subsidiary, Headspace Health.

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Interview: André Schmidt, CEO, Median Kliniken

Dr Schmidt gives HBI the inside view of Germany's €9-10bn rehabilitation sector in the pandemic months, from how activity dropped to what financial support it got, to its medium-term outlook. Are digital therapeutics apps like Kaia Health, which recently raised $26m, a threat?

Interview: Daniel Soukup, head of EUC Virtual Clinic

The Czech Republic's largest primary care and occupational healthcare provider by revenue, EUC, has been leading the charge in bringing digital health care to the country. Daniel Soukup, head of its Virtual Clinic, tells HBI that while the service has before been only for its private-pay patients, it is starting to work much closer with public insurers to bring telemedicine to more people.

Find Us